IFLScience on MSN
Alzheimer’s drugs that target amyloid plaques have no meaningful effects, says major review, sparking fierce debate from scientists
Alzheimer’s disease drugs that target amyloid-β, one of the problematic proteins associated with the disease, may have “no ...
Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from ...
AI analysis of Reddit posts uncovered potential side effects of GLP-1 drugs that may be underreported, demonstrating the value of social media in early drug safety insights.
These drugs were hailed by proponents as breakthroughs in the fight to treat Alzheimer’s disease, but a new independent ...
The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...
Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...
Anti-amyloid drugs have been considered game-changing for Alzheimer's, but an extensive review has revealed that the drugs ...
An AI study analyzing more than 400,000 Reddit posts identified patient-reported symptoms associated with GLP-1 medications ...
Rezdiffra (resmetirom) is a brand-name drug prescribed for a type of liver disease called metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH) ...
A medical oncologist called the late-stage clinical trial results "remarkable," though Sasse said the drug means his body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results